ID

27808

Description

Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-mortality in Patients With Chronic Heart Failure; ODM derived from: https://clinicaltrials.gov/show/NCT00853658

Link

https://clinicaltrials.gov/show/NCT00853658

Keywords

Versions (1)
  1. 11/29/17 11/29/17 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

November 29, 2017

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Chronic Heart Failure NCT00853658

English

Eligibility Chronic Heart Failure NCT00853658

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with a diagnosis of chronic heart failure (nyha class ii - iv):
Description

Chronic heart failure New York Heart Association Classification

Data type

boolean

Alias
UMLS CUI [1,1]
C0264716
UMLS CUI [1,2]
C1275491
lvef ≤ 35% at visit 1. (local measurement, measured within the past 6 months assessed by echocardiogram, muga, ct scan, mri or ventricular angiography)
Description

Left ventricular ejection fraction Echocardiography | Left ventricular ejection fraction MUGA | Left ventricular ejection fraction CT scan | Left ventricular ejection fraction MRI | Left ventricular ejection fraction Ventricular angiography

Data type

boolean

Alias
UMLS CUI [1,1]
C0428772
UMLS CUI [1,2]
C0013516
UMLS CUI [2,1]
C0428772
UMLS CUI [2,2]
C0521317
UMLS CUI [3,1]
C0428772
UMLS CUI [3,2]
C0040405
UMLS CUI [4,1]
C0428772
UMLS CUI [4,2]
C0024485
UMLS CUI [5,1]
C0428772
UMLS CUI [5,2]
C1112786
elevated bnp at visit 1: bnp ≥ 150 pg/ml (according to local measurement).
Description

Brain natriuretic peptide increased

Data type

boolean

Alias
UMLS CUI [1]
C1095988
bnp ≥ 100 pg/ml (according to local measurement) and unplanned hospitalization with hf within the last 12 months prior visit 1.
Description

Brain natriuretic peptide measurement | Hospitalization Due to Heart Failure Without Plan

Data type

boolean

Alias
UMLS CUI [1]
C1095989
UMLS CUI [2,1]
C3898876
UMLS CUI [2,2]
C0332288
UMLS CUI [2,3]
C1301732
patients must be treated with an ace inhibitor at a stable dose (enalapril 10 mg daily at least or any other ace inhibitor, e.g. ramipril, quinapril, lisinopril, fosinopril, perindopril, trandolapril; based on equivalent doses as described in the dose equivalence guidance table of acei's) for at least 4 weeks prior to visit 1
Description

Angiotensin-Converting Enzyme Inhibitors Dose Stable | Enalapril U/day | Ramipril | quinapril | Lisinopril | Fosinopril | Perindopril | trandolapril

Data type

boolean

Alias
UMLS CUI [1,1]
C0003015
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0205360
UMLS CUI [2,1]
C0014025
UMLS CUI [2,2]
C0456683
UMLS CUI [3]
C0072973
UMLS CUI [4]
C0072857
UMLS CUI [5]
C0065374
UMLS CUI [6]
C0118168
UMLS CUI [7]
C0136123
UMLS CUI [8]
C0076891
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
history of hypersensitivity to any of the study drugs including history or allergy to acei's as well as known or suspected contraindications to the study drugs or previous history of intolerance to high doses of acei's during up titration process.
Description

Hypersensitivity Investigational New Drugs | Angiotensin-converting-enzyme inhibitor allergy | Medical contraindication Investigational New Drugs | Medical contraindication Suspected Investigational New Drugs | intolerance to Angiotensin-Converting Enzyme Inhibitors High dose

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0013230
UMLS CUI [2]
C0571939
UMLS CUI [3,1]
C1301624
UMLS CUI [3,2]
C0013230
UMLS CUI [4,1]
C1301624
UMLS CUI [4,2]
C0750491
UMLS CUI [4,3]
C0013230
UMLS CUI [5,1]
C1744706
UMLS CUI [5,2]
C0003015
UMLS CUI [5,3]
C0444956
patients treated concomitantly with both arb and aldosterone antagonist in addition to study drug at visit 1.
Description

Angiotensin II receptor antagonist | Aldosterone Antagonists | Investigational New Drugs

Data type

boolean

Alias
UMLS CUI [1]
C0521942
UMLS CUI [2]
C0002007
UMLS CUI [3]
C0013230
current acute decompensated hf.
Description

Decompensated cardiac failure

Data type

boolean

Alias
UMLS CUI [1]
C0581377
symptomatic hypotension and/or less than 95 mmhg sbp at visit 1 and/or less than 90 mmhg at visit 4.
Description

Hypotension symptomatic | Systolic Pressure

Data type

boolean

Alias
UMLS CUI [1]
C0863113
UMLS CUI [2]
C0871470
renal disease likely to be life threatening or egfr < 40 ml/min/1.73m2 as measured by the mdrd formula at visit 1 and egfr < 35 ml/min/1.73m2 as measured by the mdrd formula at visit 4 or decrease of egfr of more than 25% from visit 1 to visit 4 (according to local laboratory measurement).
Description

Kidney Disease Life Threatening | Estimated Glomerular Filtration Rate Creatinine-based formula (MDRD) | Decreased glomerular filtration rate Percentage

Data type

boolean

Alias
UMLS CUI [1,1]
C0022658
UMLS CUI [1,2]
C2826244
UMLS CUI [2,1]
C3811844
UMLS CUI [2,2]
C1980036
UMLS CUI [3,1]
C0853068
UMLS CUI [3,2]
C0439165
serum potassium ≥ 5.0 mmol/l at visit 1 or ≥ 5.2 mmol/l at visit 4 (according to local laboratory measurement).
Description

Serum potassium measurement

Data type

boolean

Alias
UMLS CUI [1]
C0302353
acute coronary syndrome, stroke, transient ischemic attack, cardiac, carotid or major vascular surgery, percutaneous coronary intervention (pci) or carotid angioplasty, within the past 3 months prior to visit 1.
Description

Acute Coronary Syndrome | Cerebrovascular accident | Transient Ischemic Attack | Cardiac Surgery procedures | Carotid surgery | Vascular Surgical Procedures Major | Percutaneous Coronary Intervention | Carotid angioplasty

Data type

boolean

Alias
UMLS CUI [1]
C0948089
UMLS CUI [2]
C0038454
UMLS CUI [3]
C0007787
UMLS CUI [4]
C0018821
UMLS CUI [5]
C0741984
UMLS CUI [6,1]
C0042381
UMLS CUI [6,2]
C0205164
UMLS CUI [7]
C1532338
UMLS CUI [8]
C3203476
coronary or carotid artery disease likely to require surgical or percutaneous intervention within the 6 months after visit 1.
Description

Coronary Artery Disease Requirement Operative Surgical Procedures | Carotid Artery Disease Requirement Operative Surgical Procedures | Coronary Artery Disease Requirement Intervention Percutaneous | Carotid Artery Disease Requirement Intervention Percutaneous

Data type

boolean

Alias
UMLS CUI [1,1]
C1956346
UMLS CUI [1,2]
C1514873
UMLS CUI [1,3]
C0543467
UMLS CUI [2,1]
C0007273
UMLS CUI [2,2]
C1514873
UMLS CUI [2,3]
C0543467
UMLS CUI [3,1]
C1956346
UMLS CUI [3,2]
C1514873
UMLS CUI [3,3]
C0184661
UMLS CUI [3,4]
C0522523
UMLS CUI [4,1]
C0007273
UMLS CUI [4,2]
C1514873
UMLS CUI [4,3]
C0184661
UMLS CUI [4,4]
C0522523
right heart failure due to severe pulmonary disease
Description

Right Heart Failure Due to Lung disease Severe

Data type

boolean

Alias
UMLS CUI [1,1]
C0235527
UMLS CUI [1,2]
C0678226
UMLS CUI [1,3]
C0024115
UMLS CUI [1,4]
C0205082
other protocol-defined inclusion/exclusion criteria may apply
Description

Eligibility Criteria Study Protocol

Data type

boolean

Alias
UMLS CUI [1,1]
C1516637
UMLS CUI [1,2]
C2348563
Back to the top of the page

Similar models

Eligibility Chronic Heart Failure NCT00853658

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Chronic heart failure New York Heart Association Classification
Item
patients with a diagnosis of chronic heart failure (nyha class ii - iv):
boolean
C0264716 (UMLS CUI [1,1])
C1275491 (UMLS CUI [1,2])
Left ventricular ejection fraction Echocardiography | Left ventricular ejection fraction MUGA | Left ventricular ejection fraction CT scan | Left ventricular ejection fraction MRI | Left ventricular ejection fraction Ventricular angiography
Item
lvef ≤ 35% at visit 1. (local measurement, measured within the past 6 months assessed by echocardiogram, muga, ct scan, mri or ventricular angiography)
boolean
C0428772 (UMLS CUI [1,1])
C0013516 (UMLS CUI [1,2])
C0428772 (UMLS CUI [2,1])
C0521317 (UMLS CUI [2,2])
C0428772 (UMLS CUI [3,1])
C0040405 (UMLS CUI [3,2])
C0428772 (UMLS CUI [4,1])
C0024485 (UMLS CUI [4,2])
C0428772 (UMLS CUI [5,1])
C1112786 (UMLS CUI [5,2])
Brain natriuretic peptide increased
Item
elevated bnp at visit 1: bnp ≥ 150 pg/ml (according to local measurement).
boolean
C1095988 (UMLS CUI [1])
Brain natriuretic peptide measurement | Hospitalization Due to Heart Failure Without Plan
Item
bnp ≥ 100 pg/ml (according to local measurement) and unplanned hospitalization with hf within the last 12 months prior visit 1.
boolean
C1095989 (UMLS CUI [1])
C3898876 (UMLS CUI [2,1])
C0332288 (UMLS CUI [2,2])
C1301732 (UMLS CUI [2,3])
Angiotensin-Converting Enzyme Inhibitors Dose Stable | Enalapril U/day | Ramipril | quinapril | Lisinopril | Fosinopril | Perindopril | trandolapril
Item
patients must be treated with an ace inhibitor at a stable dose (enalapril 10 mg daily at least or any other ace inhibitor, e.g. ramipril, quinapril, lisinopril, fosinopril, perindopril, trandolapril; based on equivalent doses as described in the dose equivalence guidance table of acei's) for at least 4 weeks prior to visit 1
boolean
C0003015 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0014025 (UMLS CUI [2,1])
C0456683 (UMLS CUI [2,2])
C0072973 (UMLS CUI [3])
C0072857 (UMLS CUI [4])
C0065374 (UMLS CUI [5])
C0118168 (UMLS CUI [6])
C0136123 (UMLS CUI [7])
C0076891 (UMLS CUI [8])
Item Group
C0680251 (UMLS CUI)
Hypersensitivity Investigational New Drugs | Angiotensin-converting-enzyme inhibitor allergy | Medical contraindication Investigational New Drugs | Medical contraindication Suspected Investigational New Drugs | intolerance to Angiotensin-Converting Enzyme Inhibitors High dose
Item
history of hypersensitivity to any of the study drugs including history or allergy to acei's as well as known or suspected contraindications to the study drugs or previous history of intolerance to high doses of acei's during up titration process.
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0571939 (UMLS CUI [2])
C1301624 (UMLS CUI [3,1])
C0013230 (UMLS CUI [3,2])
C1301624 (UMLS CUI [4,1])
C0750491 (UMLS CUI [4,2])
C0013230 (UMLS CUI [4,3])
C1744706 (UMLS CUI [5,1])
C0003015 (UMLS CUI [5,2])
C0444956 (UMLS CUI [5,3])
Angiotensin II receptor antagonist | Aldosterone Antagonists | Investigational New Drugs
Item
patients treated concomitantly with both arb and aldosterone antagonist in addition to study drug at visit 1.
boolean
C0521942 (UMLS CUI [1])
C0002007 (UMLS CUI [2])
C0013230 (UMLS CUI [3])
Decompensated cardiac failure
Item
current acute decompensated hf.
boolean
C0581377 (UMLS CUI [1])
Hypotension symptomatic | Systolic Pressure
Item
symptomatic hypotension and/or less than 95 mmhg sbp at visit 1 and/or less than 90 mmhg at visit 4.
boolean
C0863113 (UMLS CUI [1])
C0871470 (UMLS CUI [2])
Kidney Disease Life Threatening | Estimated Glomerular Filtration Rate Creatinine-based formula (MDRD) | Decreased glomerular filtration rate Percentage
Item
renal disease likely to be life threatening or egfr < 40 ml/min/1.73m2 as measured by the mdrd formula at visit 1 and egfr < 35 ml/min/1.73m2 as measured by the mdrd formula at visit 4 or decrease of egfr of more than 25% from visit 1 to visit 4 (according to local laboratory measurement).
boolean
C0022658 (UMLS CUI [1,1])
C2826244 (UMLS CUI [1,2])
C3811844 (UMLS CUI [2,1])
C1980036 (UMLS CUI [2,2])
C0853068 (UMLS CUI [3,1])
C0439165 (UMLS CUI [3,2])
Serum potassium measurement
Item
serum potassium ≥ 5.0 mmol/l at visit 1 or ≥ 5.2 mmol/l at visit 4 (according to local laboratory measurement).
boolean
C0302353 (UMLS CUI [1])
Acute Coronary Syndrome | Cerebrovascular accident | Transient Ischemic Attack | Cardiac Surgery procedures | Carotid surgery | Vascular Surgical Procedures Major | Percutaneous Coronary Intervention | Carotid angioplasty
Item
acute coronary syndrome, stroke, transient ischemic attack, cardiac, carotid or major vascular surgery, percutaneous coronary intervention (pci) or carotid angioplasty, within the past 3 months prior to visit 1.
boolean
C0948089 (UMLS CUI [1])
C0038454 (UMLS CUI [2])
C0007787 (UMLS CUI [3])
C0018821 (UMLS CUI [4])
C0741984 (UMLS CUI [5])
C0042381 (UMLS CUI [6,1])
C0205164 (UMLS CUI [6,2])
C1532338 (UMLS CUI [7])
C3203476 (UMLS CUI [8])
Coronary Artery Disease Requirement Operative Surgical Procedures | Carotid Artery Disease Requirement Operative Surgical Procedures | Coronary Artery Disease Requirement Intervention Percutaneous | Carotid Artery Disease Requirement Intervention Percutaneous
Item
coronary or carotid artery disease likely to require surgical or percutaneous intervention within the 6 months after visit 1.
boolean
C1956346 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
C0543467 (UMLS CUI [1,3])
C0007273 (UMLS CUI [2,1])
C1514873 (UMLS CUI [2,2])
C0543467 (UMLS CUI [2,3])
C1956346 (UMLS CUI [3,1])
C1514873 (UMLS CUI [3,2])
C0184661 (UMLS CUI [3,3])
C0522523 (UMLS CUI [3,4])
C0007273 (UMLS CUI [4,1])
C1514873 (UMLS CUI [4,2])
C0184661 (UMLS CUI [4,3])
C0522523 (UMLS CUI [4,4])
Right Heart Failure Due to Lung disease Severe
Item
right heart failure due to severe pulmonary disease
boolean
C0235527 (UMLS CUI [1,1])
C0678226 (UMLS CUI [1,2])
C0024115 (UMLS CUI [1,3])
C0205082 (UMLS CUI [1,4])
Eligibility Criteria Study Protocol
Item
other protocol-defined inclusion/exclusion criteria may apply
boolean
C1516637 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial